A recent real-world study, POSEIDON, reveals a significant prevalence of cardiovascular inflammation in patients with both heart failure and chronic kidney disease (CKD). The findings indicate that approximately two in five patients with these combined conditions exhibit elevated levels of cardiovascular inflammation. This suggests inflammation may be a key factor in the progression of cardiovascular disease within this vulnerable patient population. Researchers analyzed data from a broad, real-world setting to assess the extent of this inflammation. The study highlights the need for further investigation into the role of inflammation in managing and treating individuals with co-existing heart failure and CKD. Understanding this connection could lead to improved diagnostic and therapeutic strategies for these patients.